Comparing Two Measures of Creatinine Clearance: an Application of 
Errors-in-Variables and Bootstrap Techniques

By S. D. Oman, N. Meir and N. Haim

Applied Statistics



Repeated observations on consecutive patients who underwent cisplatin
chemotherapy in the Department of Oncology at Hadassah Hebrew University
Hospital, Jerusalem, Israel.

 VARIABLES:

1  ID of patient
2  SEX (1 = F, 2 = M)
3  TEST (observation) number (approx 1 - 12)
4  DATE of test (ddmmyy)
5  AGE of patient (yrs)
6  WEIGHT (kg)
7  SERUMCR Concentration of creatinine in blood (mg/ml)
8  URINECR Concentration of creatinine in urine (mg/ml)
9  URINEVOL Volume of urine collected in 24 hrs (ml)
10 CUMDRUG  Cumulative amount of drug (cisplatin) administered (mg/m**2)
11 HEIGHT of patient (cm)
12 ignore this
13 FLUID Third type body fluids (0=none; 1=present)
14 TYPE  0: Patient reached listed value of CUMDRUG approx. 10 days before (at
            the previous visit).
         1: Patient has been at listed value of CUMDRUG for more than since the
            last visit; i.e., on the previous visit his dose was not increased.
15 ignore this

Editor's note:
There are 254 observations on 61 females and 184 observations on 50 males.
N.B.  Female patient with ID 61 (one reading) was not analysed in the paper.